Wordt geladen...
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
Background Tocilizumab is an IL-6 receptor-blocking agent proposed for the treatment of severe COVID-19. The aim of this systematic review was to describe the rationale for the use of tocilizumab for the treatment of COVID-19 and to summarize the available evidence regarding its efficacy and safety....
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2021-01-01
|
| Reeks: | Pulmonology |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1016/j.pulmoe.2020.07.003 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|